Parnax Lab
Company Overview - January 14, 2025
Parnax Lab is a notable player in the Pharmaceuticals - Indian - Formulations industry, listed on the BSE (Code: 506128). As of the January 14, 2025, the company holds a market capitalization of INR 203.29 crores, placing it among the top-performing companies in its sector.
With a current stock price of INR 177.00, Parnax Lab has demonstrated a 79.77% return over the last year. Recent performance indicates fluctuations, with a 9.67% change in the past week and a 23.00% change over the last month. The company's all-time high stands at INR 193.50, while its lowest-ever price was INR 8.40.
In terms of sales, Parnax Lab reported a revenue of INR 195.84 crores, solidifying its position in the market. The average trading volume over the past month has been 49637 shares, with a more recent weekly average of 35953.
With the stock trading above its 50-day moving average of INR 145.06, the company's technical indicators like MACD (8.45) signal positive trends.
Company Data
Name | Parnax Lab |
---|---|
BSE Code | 506128 |
NSE Code | |
Industry | Pharmaceuticals - Indian - Formulations |
Current Price | 177.00 |
Market Capitalization | 203.29 |
Sales | 195.84 |
Return over 3months | 48.17 |
Return over 6months | 82.85 |
Volume 1month average | 49637 |
Volume 1week average | 35953 |
Volume | 21633 |
High price | 193.50 |
Low price | 80.00 |
High price all time | 193.50 |
Low price all time | 8.40 |
Return over 1day | -0.62 |
Return over 1week | 9.67 |
Return over 1month | 23.00 |
Return over 1year | 79.77 |
Return over 3years | 72.50 |
Return over 5years | 56.21 |
Volume 1year average | 21501 |
DMA 50 | 145.06 |
DMA 200 | 119.37 |
DMA 50 previous day | 143.71 |
DMA 200 previous day | 118.78 |
MACD | 8.45 |
MACD Signal | 6.77 |